Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates. It specializes in improving the solubility and bioavailability of poorly water-soluble drugs using its suite of nanotechnology platforms. Ascendia formulates products for injectable, oral, and topical routes ofadministration. The company has three technology platforms - EmulSol for producing nano-emulsions, AmorSol for creating amorphous solid dispersions, and NanoSol for formulating nano-particles.

Biotechnology

Health Care

Pharmaceutical

Ascendia

Ascendia's headquarters in North Brunswick, NJ, United States

Description

People (14)

Shaukat Ali

Kaoru Tominaga

Xinyu Wang Ph. D.

Christopher Todd

Jose Parra

Junling Wang

Kathy Avalos

Wenjiao Song

Nitprapa Siriwannakij

Zhifeng Zhao

Robert Bloder

Jason Oliver

M Asif

James Tom

Jobs